Back to Search
JAE KIM, M.D.
M.D.
Facial Plastic Surgery Physician
NPI: 1609168327IndividualAccepts Medicare
Specialties, Licenses & Credentials
Facial Plastic Surgery PhysicianPrimary
Otolaryngology — Facial Plastic Surgery
Code: 207YS0123X
0101259733(VA)
Otolaryngology Physician
Otolaryngology
Code: 207Y00000X
0101259733(VA)
Education
STATE UNIVERSITY OF NEW YORK AT BUFFALO SCHOOL OF MEDICINE
Class of 2011
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Psoriasis harbors multiple pathogenic type 17 T-cell subsets: Selective modulation by risankizumab.
PMID 39978685·J Allergy Clin Immunol·2025
8-other
Proportion of CD4CD49bLAG-3Type 1 Regulatory T Cells in the Blood of Psoriasis Patients Inversely Correlates with Psoriasis Area and Severity Index.
PMID 29890167·J Invest Dermatol·2018
8-other
Reduction of Inflammatory and Cardiovascular Proteins in the Blood of Patients with Psoriasis: Differential Responses between Tofacitinib and Etanercept after 4 Weeks of Treatment.
PMID 28927890·J Invest Dermatol·2018
3-trial
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
PMID 30097359·Lancet·2018
3-trial
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis.
PMID 28423301·N Engl J Med·2017
3-trial
Highly Effective New Treatments for Psoriasis Target the IL-23/Type 17 T Cell Autoimmune Axis.
PMID 27686018·Annu Rev Med·2017
6-review
The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes.
PMID 27185339·J Invest Dermatol·2016
4-observational
Molecular Phenotyping Small (Asian) versus Large (Western) Plaque Psoriasis Shows Common Activation of IL-17 Pathway Genes but Different Regulatory Gene Sets.
PMID 26763436·J Invest Dermatol·2016
4-observational
Patients With Psoriasis and Personalized Trade-offs in Treatment Decisions-Lessons Learned From Focus Groups.
PMID 27028481·JAMA Dermatol·2016
8-other
Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial.
PMID 25769911·J Allergy Clin Immunol·2015
2-rct
Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris.
PMID 14707118·J Exp Med·2004
4-observational
Needs of family caregivers caring for stroke patients: based on the rehabilitation treatment phase and the treatment setting.
PMID 17804349·Soc Work Health Care·2007
8-other
Variation of haemoglobin extinction coefficients can cause errors in the determination of haemoglobin concentration measured by near-infrared spectroscopy.
PMID 17921586·Phys Med Biol·2007
8-other
The major facilitator superfamily member Slc37a2 is a novel macrophage- specific gene selectively expressed in obese white adipose tissue.
PMID 17356011·Am J Physiol Endocrinol Metab·2007
7-preclinical
Interplay of tumor vascular oxygenation and tumor pO2 observed using near-infrared spectroscopy, an oxygen needle electrode, and 19F MR pO2 mapping.
PMID 12542380·J Biomed Opt·2003
7-preclinical
Coronary endothelial dysfunction associated with a depressive mood in patients with atypical angina but angiographically normal coronary artery.
PMID 19272659·Int J Cardiol·2010
2-rct
Child maltreatment and trajectories of personality and behavioral functioning: implications for the development of personality disorder.
PMID 19583889·Dev Psychopathol·2009
8-other
False-negative results obtained with the Gen-Probe Amplified Mycobacterium tuberculosis direct test caused by unrecognized inhibition of the amplification reaction.
PMID 19587300·J Clin Microbiol·2009
5-case
Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer.
PMID 19578399·PLoS Genet·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 2200 WILSON BLVD STE 102-219
ARLINGTON, VA 22201 - Phone
- (347) 551-1113
Quick Facts
- NPI
- 1609168327
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 15
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile